Calcium and phosphate: A duet of ions playing for bone health

Journal of the American College of Nutrition

Volumn 30, Issue , 2011, Pages 438S-448S

  Bonjour, Jean Philippe ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Bone mineralization; Ca sensing receptors; Extraskeletal Ca and Pi handling; FGF 23; Matrix vesicles; Osteoblast; Osteoclast; Pi osteocytes interaction

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM ION; FIBROBLAST GROWTH FACTOR 23; HYDROXYAPATITE; PHOSPHATE; FIBROBLAST GROWTH FACTOR;

BONE MASS; BONE METABOLISM; BONE MINERALIZATION; BONE STRENGTH; BONE STRUCTURE; BONE TISSUE; CELL MEMBRANE; CELL MIGRATION; DAIRY PRODUCT; HUMAN; MILK; NONHUMAN; NUTRITION; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; PHYSICAL ACTIVITY; REVIEW; BONE; BONE DEVELOPMENT; CALCIUM INTAKE; DRUG EFFECT; METABOLISM; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BONE AND BONES; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CALCIUM, DIETARY; DAIRY PRODUCTS; FIBROBLAST GROWTH FACTORS; HUMANS; OSTEOGENESIS; PHOSPHATES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84857940901     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2011.10719988     Document Type: Article

References (86)

1. RobeyPG, BoskeyAL: The composition of bone. In Rosen CJ, Compston JE, Lian JB (eds): “Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.”Washington, DC: The American Society of Bone and Mineral Research, pp 32-38, 2008.
2. DiemK, LentnerC: “Tables Scientifiques.” Basel, Switzerland: Ciba-Geigy SA, 1972.
3. Guéguen L: Minéraux et oligoéléments. In Debry G (ed): “Lait, Nutrition et Santé.” Paris, New York, London: Editions TEC & DOC, pp 125-149, 2001.
4. MillerGD, JarvisKJ, McBeanLD: “Handbook of Dairy Foods and Nutrition,” 2nd ed. Boca Raton, FL: CRC Press, 2000.
5. AFSSA: “Individual and national study on food consumption 2 (INCA 2) 2006-2007.” Agence Française de Sécurité Sanitaire des Aliment, 2009. Accessed at: www.anses.fr
6. NeumanWF, NeumanMW: “The Chemical Dynamics of Bone Mineral.” Chicago: University of Chicago Press, 1958.
7. WuthierRE: Mechanism of de novo mineral formation by matrix vesicles. Connect Tissue Res 22: 27-33, discussion53-61, 1989.
8. MontessuitC, CaverzasioJ, BonjourJP: Characterization of a Pi transport system in cartilage matrix vesicles. Potential role in the calcification process. J Biol Chem266: 17791-17797, 1991.
9. MontessuitC, BonjourJP, CaverzasioJ: Expression and regulation of Na-dependent P(i) transport in matrix vesicles produced by osteoblast-like cells. J Bone Miner Res10: 625-631, 1995.
10. CaverzasioJ, BonjourJP: Characteristics and regulation of Pi transport in osteogenic cells for bone metabolism. Kidney Int49: 975-980, 1996.
11. PalmerG, ManenD, BonjourJP, CaverzasioJ: Characterization of the human Glvr-1 phosphate transporter/retrovirus receptor gene and promoter region. Gene226: 25-33, 1999.
12. SuzukiA, GhayorC, GuicheuxJ, MagneD, QuillardS, KakitaA, OnoY, MiuraY, OisoY, ItohM, CaverzasioJ: Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res21: 674-683, 2006.
13. HuesaC, YadavMC, FinnilaMA, GoodyearSR, RobinsSP, TannerKE, AspdenRM, MillanJL, FarquharsonC: PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. Bone 48: 1066-1074, 2011.
14. WhyteM-P: Enzyme defects and the skeleton. In Rosen CJ, Compston JE, Lian JB (eds): “Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.” Washington, DC: The American Society for Bone and Mineral Research, pp 454- 458, 2008.
15. OrimoH: The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch77: 4-12, 2011.
16. MariePJ: The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. Bone46: 571-576, 2010.
17. HaldimannB, BonjourJP, FleischH: Role of parathyroid hormone in regulation of main calcium fluxes in rats. Am J Physiol232: E535-E541, 1977.
18. OrrJB: Influence of amount of milk consumption on the rate of growth of school children. Br Med J1: 140-141, 1928.
19. LeightonG, ClarkML: Milk Consumption and the growth of school children: second preliminary report on tests to the Scottish Board of Health. Br Med J1: 23-25, 1929.
20. CadoganJ, EastellR, JonesN, BarkerME: Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. Br Med J315: 1255-1260, 1997.
21. BonjourJP, CarrieAL, FerrariS, ClavienH, SlosmanD, TheintzG, RizzoliR: Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest99: 1287-1294, 1997.
22. PrenticeA: Calcium Supplementation increases height and bone mass in 16-18 year old boys. J Bone Miner Res17: S397, 2002.
23. ChevalleyT, RizzoliR, HansD, FerrariS, BonjourJP: Interaction between calcium intake and menarcheal age on bone mass gain: an eight-year follow-up study from prepuberty to postmenarche. J Clin Endocrinol Metab90: 44-51, 2005.
24. BonjourJP, ChevalleyT, RizzoliR, FerrariS: Gene-environment interactions in the skeletal response to nutrition and exercise during growth. Med Sport Sci51: 64-80, 2007.
25. SpeckerB, VukovichM: Evidence for an interaction between exercise and nutrition for improved bone health during growth. Med Sport Sci51: 50-63, 2007.
26. ChevalleyT, BonjourJP, FerrariS, RizzoliR: High-protein intake enhances the positive impact of physical activity on BMC in prepubertal boys. J Bone Miner Res23: 131-142, 2008.
27. DvorakMM, SiddiquaA, WardDT, CarterDH, DallasSL, NemethEF, RiccardiD: Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A101: 5140-5145, 2004.
28. BrownEM, MacLeodRJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev81: 239-297, 2001.
29. ChangW, TuC, ChenTH, KomuvesL, OdaY, PrattSA, MillerS, ShobackD: Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology140: 5883-5893, 1999.
30. MentaverriR, YanoS, ChattopadhyayN, PetitL, KiforO, KamelS, TerwilligerEF, BrazierM, BrownEM: The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J20: 2562-2564, 2006.
31. BinghamPJ, RaiszLG: Bone growth in organ culture: effects of phosphate and other nutrients on bone and cartilage. Calcif Tissue Res14: 31-48, 1974.
32. BonewaldLF: Ostecytes. In Rosen CJ, Compston JE, Lian JB (eds): “Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.”Washington, DC: The American Society of Bone and Mineral Research, pp 22-27, 2008.
33. Franz-OdendaalTA, HallBK, WittenPE: Buried alive: how osteoblasts become osteocytes. Dev Dyn235: 176-190, 2006.
34. IrieK, EjiriS, SakakuraY, ShibuiT, YajimaT: Matrix mineralization as a trigger for osteocyte maturation. J Histochem Cytochem56: 561-567, 2008.
35. van BezooijenRL, ten DijkeP, PapapoulosSE, LowikCW: SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev16: 319-327, 2005.
36. DallasSL, BonewaldLF: Dynamics of the transition from osteoblast to osteocyte. Ann N Y Acad Sci1192: 437-443, 2010.
37. ZhangR, LuY, YeL, YuanB, YuS, QinC, XieY, GaoT, DreznerMK, BonewaldLF, FengJQ: Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J Bone Miner Res26: 1047-1056, 2011.
38. LuY, YuanB, QinC, CaoZ, XieY, DallasSL, McKeeMD, DreznerMK, BonewaldLF, FengJQ: The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa Cterminal fragment. J Bone Miner Res26: 331-340, 2011.
39. FengJQ, WardLM, LiuS, LuY, XieY, YuanB, YuX, RauchF, DavisSI, ZhangS, RiosH, DreznerMK, QuarlesLD, BonewaldLF, WhiteKE: Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet38: 1310-1315, 2006.
40. UrakawaI, YamazakiY, ShimadaT, IijimaK, HasegawaH, OkawaK, FujitaT, FukumotoS, YamashitaT: Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature444: 770-774, 2006.
41. KurosuH, KuroOM: The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 299: 72-78, 2009.
42. BonjourJP, TrohlerU, MuhlbauerR, PrestonC, FleischH: Is there a bone-kidney link in the homeostasis of inorganic phosphate (Pi)?Adv Exp Med Biol81: 319-322, 1977.
43. BonjourJP, TroehlerU, PrestonC, FleischH: Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates. Am J Physiol234: F497-F505, 1978.
44. SchenkR, MerzWA, MuhlbauerR, RussellRG, FleischH: Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res11: 196-214, 1973.
45. TrohlerU, BonjourJP, FleischH: Inorganic phosphate homeostasis. Renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats. J Clin Invest57: 264-273, 1976.
46. BonjourJP, CaverzasioJ, FleischH, MuhlbauerR, TroehlerU: The adaptive system of the tubular transport of phosphate. Adv Exp Med Biol151: 1-11, 1982.
47. FukumotoS: Physiological regulation and disorders of phosphate metabolism—pivotal role of fibroblast growth factor 23. Intern Med47: 337-343, 2008.
48. MuhlbauerRC, BonjourJP, FleischH: Abnormal tubular adaptation to dietary Pi restriction in X-linked hypophosphatemic mice. Am J Physiol242: F353-F359, 1982.
49. InsognaKL, BroadusAE, GertnerJM: Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets. J Clin Invest71: 1562-1569, 1983.
50. KanataniM, SugimotoT, KanoJ, KanzawaM, ChiharaK: Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. J Cell Physiol196: 180-189, 2003.
51. MozarA, HarenN, ChasseraudM, LouvetL, MaziereC, WattelA, MentaverriR, MorliereP, KamelS, BrazierM, MaziereJC, MassyZA: High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells. J Cell Physiol215: 47-54, 2008.
52. RizzoliR, BonjourJP: Physiology of calcium and phosphate homeostasis. In Seibel MJ, Robins SP, Bilezikian JP (eds): “Dynamics of Bone and Cartilage Metabolism: Principles and Clinical Applications.” San Diego: Academic Press, pp 345-360, 2006.
53. LambersTT, BindelsRJ, HoenderopJG: Coordinated control of renal Ca2þ handling. Kidney Int69: 650-654, 2006.
54. BindelsRJ: 2009Homer W. Smith Award: Minerals in motion: from new ion transporters to new concepts. J Am Soc Nephrol 21: 1263-1269, 2010.
55. MurerH, BiberJ: Phosphate transport in the kidney. J Nephrol23(suppl 16): S145-S151, 2010.
56. PrieD, FriedlanderG: Genetic disorders of renal phosphate transport. N Engl J Med362: 2399-2409, 2010.
57. FerrariSL, BonjourJP, RizzoliR: Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab90: 1519-1524, 2005.
58. CaverzasioJ, MontessuitC, BonjourJP: Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25- dihydroxyvitamin D3. Endocrinology127: 453-459, 1990.
59. CaverzasioJ, BonjourJP: IGF-I, a key regulator of renal phosphate transport and 1,25-Dihydroxyvitamine D3 production during growth. News Physiol Sci6: 206-210, 1991.
60. BonjourJP, TheintzG, BuchsB, SlosmanD, RizzoliR: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab73: 555-563, 1991.
61. TheintzG, BuchsB, RizzoliR, SlosmanD, ClavienH, SizonenkoPC, BonjourJP: Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab75: 1060-1065, 1992.
62. BonjourJP, ChevalleyT, FerrariS, RizzoliR: Bone and its characteristics during childhood and adolescence up to peak bone mass. In Roux C (ed): “The Living Skeleton.” Paris: Wolters Kluwer Health France, pp 1-25, 2007.
63. BonjourJP, ChevalleyT, FerrariS, RizzoliR: Peak bone mass and its regulation. In Glorieux FH, Pettifor FM, Jüppner H (eds): “Pediatric Bone.” Amsterdam: Academic Press, in press.
64. Rizzoli R, Bianchi ML, Garabedian M, McKay HA, Moreno LA: Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 46: 294-305, 2010.
65. ChapuyMC, ArlotME, DuboeufF, BrunJ, CrouzetB, ArnaudS, DelmasPD, MeunierPJ: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med327: 1637-1642, 1992.
66. BoonenS, LipsP, BouillonR, Bischoff-FerrariHA, VanderschuerenD, HaentjensP: Need for additional calcium to reduce the risk of hip fracture with vitamin D Supplementation: evidence from a comparative meta-analysis of randomized controlled trials. J Clin Endocrinol Metab92: 1415-1423, 2007.
67. DavisonKS, KendlerDL, AmmannP, BauerDC, DempsterDW, DianL, HanleyDA, HarrisST, McClungMR, OlszynskiWP, YuenCK: Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond. Am J Med122: 992-997, 2009.
68. HeaneyRP, McCarronDA, Dawson-HughesB, OparilS, BergaSL, SternJS, BarrSI, RosenCJ: Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc99: 1228-1233, 1999.
69. BonjourJP, Brandolini-BunlonM, BoirieY, Morel-LaporteF, BraescoV, BertiereMC, SouberbielleJC: Inhibition of bone turnover by milk intake in postmenopausal women. Br J Nutr100: 866-874, 2008.
70. BonjourJP, BenoitV, PourchaireO, FerryM, RousseauB, SouberbielleJC: Inhibition of markers of bone resorption by consumption of vitamin D and calcium-fortified soft plain cheese by institutionalised elderly women. Br J Nutr102: 962-966, 2009.
71. BonjourJP, BenoitV, PourchaireO, RousseauB, SouberbielleJC: Nutritional approach for inhibiting bone resorption in institutionalized elderly women with vitamin D deficiency and high prevalence of fracture. J Nutr Health Aging15: 404-409, 2011.
72. FentonTR, LyonAW, EliasziwM, ToughSC, HanleyDA: Phosphate decreases urine calcium and increases calcium balance: a meta-analysis of the osteoporosis acid-ash diet hypothesis. Nutr J8: 41, 2009.
73. CoburnJW, MassrySG: Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. J Clin Invest49: 1073-1087, 1970.
74. GoldfarbS, WestbyGR, GoldbergM, AgusZS: Renal tubular &fjeffects of chronic phosphate depletion. J Clin Invest 59: 770-779, 1977.
75. LauK, GoldfarbS, GoldbergM, AgusZS: Effects of phosphate administration on tubular calcium transport. J Lab Clin Med99: 317-324, 1982.
76. MuhlbauerRC, BonjourJP, FleischH: Decrease in the tubular reabsorption of calcium with evidence for compensatory hyperparathyroidism in X-linked hypophosphataemia in mice. Clin Sci (Lond)62: 503-508, 1982.
77. GueguenL, PointillartA: The bioavailability of dietary calcium. J Am Coll Nutr19: 119S-136S, 2000.
78. HeaneyRP: Absorbability and utility of calcium in mineral waters. Am J Clin Nutr84: 371-374, 2006.
79. KarpHJ, VaihiaKP, KarkkainenMU, NiemistoMJ, Lamberg- AllardtCJ: Acute effects of different phosphorus sources on calcium and bone metabolism in young women: a whole-foods approach. Calcif Tissue Int80: 251-258, 2007.
80. BonjourJP, GueguenL, PalaciosC, ShearerMJ, WeaverCM: Minerals and vitamins in bone health: the potential value of dietary enhancement. Br J Nutr101: 1581-1596, 2009.
81. CalvoMS: The effects of high phosphorus intake on calcium homeostasis. Adv Nutr Res9: 183-207, 1994.
82. HeaneyRP: Phosphorus nutrition and the treatment of osteoporosis. Mayo Clin Proc79: 91-97, 2004.
83. HeaneyRP, NordinBE: Calcium effects on phosphorus absorption: implications for the prevention and co-therapy of osteoporosis. J Am Coll Nutr21: 239-244, 2002.
84. NeerRM, ArnaudCD, ZanchettaJR, PrinceR, GaichGA, ReginsterJY, HodsmanAB, EriksenEF, Ish-ShalomS, GenantHK, WangO, MitlakBH: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med344: 1434-1441, 2001.
85. DruekeTB: Lanthanum carbonate as a first-line phosphate binder: the “cons.” Semin Dial20: 329-332, 2007.
86. BollandMJ, AvenellA, BaronJA, GreyA, MacLennanGS, GambleGD, ReidIR: Effect of calcium Supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. Br Med J341: 2011.